Protagonist Therapeutics, Inc. (PTGX) Discusses FDA Approval of ICOTYDE for Moderate to Severe Plaque Psoriasis Treatment - Slideshow
Corroborated by 2 sources from 2 publishers
ushealth2d ago
TL;DR
Reports differ across sources; according to seekingalpha.com, protagonist Therapeutics, Inc. (PTGX) Discusses FDA Approval of ICOTYDE for Moderate to Severe Plaque Psoriasis Treatment - Slideshow.
Sources
1
Seeking Alpha Market News
https://seekingalpha.com/article/4883743-protagonist-therapeutics-inc-ptgx-discusses-fda-approval-of-icotyde-for-moderate-to-severe?source=feed_all_articles
2d ago
2
CNBC
https://www.cnbc.com/2026/03/18/icotyde-psoriasis-pill-from-jj-to-rival-tremfya-skyrizi-il-23-shots.html
2d ago
3
Seeking Alpha Market News
https://seekingalpha.com/article/4883741-protagonist-therapeutics-inc-ptgx-discusses-fda-approval-of-icotyde-for-moderate-to-severe?source=feed_all_articles
2d ago